China Medical System Holdings Limited (HKG:0867)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
10.60
+0.02 (0.19%)
Nov 6, 2026, 4:08 PM HKT

HKG:0867 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
8,7118,2127,4698,0139,1508,337
Revenue Growth
6.07%9.95%-6.79%-12.43%9.75%20.03%
Gross Profit
6,2005,8725,4226,0767,0366,247
Operating Income
1,7371,5781,6502,7133,5523,151
Net Income
1,5341,4891,6202,4013,2593,017
Earnings Per Share
0.630.620.670.981.331.22
EPS Growth
2.99%-7.78%-31.85%-26.27%8.61%19.45%

Revenue by Segment

Fiscal Year
TTMFY 2025FY 2024
Period EndingJun '26 Dec '25 Dec '24
Integrated Business
7,3407,1756,962
Skin Health Business
1,3641,070617.53
Elimination
6.63-32.6-110.11
Total
8,7118,2127,469

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
5,7535,7865,8676,1435,8774,364
Total Debt
882.94690.08860.741,3191,8131,714
Net Cash (Debt)
4,8705,0965,0064,8244,0642,649
Net Cash Growth
-4.44%1.80%3.76%18.71%53.40%28.22%
Net Cash Per Share
2.012.112.061.971.661.07

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-758.421,2692,5033,5532,494
Capital Expenditures
--41.04-32.62-27.49-18.34-23.35
Free Cash Flow
-717.381,2362,4753,5352,471
Free Cash Flow Growth
--41.96%-50.07%-29.97%43.08%-6.93%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
71.18%71.50%72.60%75.82%76.89%74.93%
Operating Margin
19.94%19.22%22.10%33.85%38.82%37.80%
Pretax Margin
24.68%25.61%26.92%35.86%41.12%41.46%
Profit Margin
17.61%18.13%21.69%29.96%35.62%36.19%
FCF Margin
-8.74%16.55%30.89%38.63%29.63%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
0.3410.2920.2680.3920.5340.491
Dividend Per Share Growth
15.44%8.95%-31.55%-26.70%8.84%18.66%
Dividend Yield
3.21%2.52%3.78%3.12%4.92%4.63%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
14.4918.8210.5812.838.178.64
Forward PE
10.1514.818.778.907.717.97
P/FCF Ratio
-39.0513.8712.447.5410.55
PS Ratio
2.563.412.303.842.913.13